RGCC Testing: Baseline and Monitoring

Cancer Testing

Step 1:

Onco-D-Clare - to determine if the immune system picks up the conversion from normal to abnormal at the cellular level.

• No pre-requisites for testing

Step 2:

Oncotrace - to determine the presence of CTCs and stemness markers.

Onconomics Plus- to determine the specific genetics of the cancer

• The patient needs to be off of particular therapies (listed below) for 14 days before testing
• The only exception is Ivermectin, which is 21 days

Step 3:

Review of Testing - with RGCC-certified practitioner

• If CTCs present- 100% positivity, the patient has cancer
• If the patient is engaging in SOT, follow the exact requirements for the blood draw for the SOT

Step 4:

Treatment and Re-Testing

• An Oncotrace will be ordered every four months to monitor CTCs and stemness markers and evaluate the protocol's effectiveness.
• Onconomics Plus: An Onconomics Plus will be ordered every 12 months. Cancer cells mutate over time, and the substances that showed efficacy on the first test may have changed. It is essential to update this information to ensure the protocols will have the most significant effect based on the state and susceptibility of the cancer cells at this new point in time.

Substances to Remove Before Testing (Cancer only)

No Need to Avoid

• Hyperthermia (generalized/systemic)
• Cryoablation

AVOID for at least 7 days

• PEMF
• Rife
• Hyperbaric Oxygen Therapy

AVOID for at least 14 days before testing.

• Natural Cytotoxic Substances (IV): (Includes Vitamin C, Ozone, H202, Colloidal Silver, Artesunate, Curcumin, etc.)
• Natural Substances (oral): cytotoxic substances (per patient’s Onconomics Plus results)
• Chemotherapy (non-platinum derivative)
• Methylene Blue
• Low Dose Naltrexone (LDN)
• MOAB or SMW drugs
• Radiation Therapy
• Imaging Scan with Contrast
• Surgery (simple/routine)

AVOID for at least 21 days before testing

• Off-label medications – such as Ivermectin, FenBen, and Itraconazole
• Chemotherapy (platinum derivative)

AVOID for 30 days or more

• Hormone Suppression Therapy – take half-life and times it by 5 (Ex. 5 hours x 5 = 1 day)
• Hyperthermia (local/concentrated/microwave ablation): at least 30 days due to an increase in cellular debris released into the bloodstream
• Surgery (brain or extensive): minimum of 30 days based on recovery time. It could be longer if there is a slow recovery or if the person has an adverse reaction. Must be evaluated on a case-by-case basis
• Blood Transfusions: at least 120 days

NOT ELIGIBLE FOR RGCC THERAPY

• Radioactive Seeds: Patients are permanently not eligible for therapy due to the prolonged and undetermined time of the radiation exposure
• Gamma Delta T Cell Therapy (GDTC): Patients are permanently not eligible for therapy due to the potential interaction with RGCC therapies.

Lyme Tests and Co-Infections

Step 1:

Draw Tickborne 2.0

• No pre-requisite is required
• The test results are good for 6 months

Step 2:

Draw for SOT

• The patient needs to be off of specific therapies for 14-21 days before the blood draw (see below)
• The patient can draw for multiple SOTs at the same time
• The patient must pay for all the SOTs being drawn
• The SOT is stable for 6 months in clinic
• SOT infusion for multiple pathogens will be done monthly

Step 3:

After SOT infusion(s)

Draw Tickborne 2.0

• No pre-requisite is required
• The test results are good for 6 months

Substances to Avoid for 21 days before SOT Therapy

For Virus/Lyme (V. Antagonist)

• Antibiotics (oral or IV)
• Antiviral medications (oral or IV)
• Anti-parasitic medications (oral or IV)
• Methylene Blue (oral and IV)
• Rife
• Scan with contrast
• IV Vitamin C
• Colloidal Silver (oral or IV)
• IV H2O2 (Hydrogen Peroxide)
• IV Ozone
• Natural Substances (ALL oral supplements that are trying to kill or suppress the same target as the SOT) (CellCore)